poisar

Stocks · News reference

Lexaria Bioscience Expands Intellectual Property Portfolio to 70 Patents

Fiscal.ai

Lexaria Bioscience Corp. announced the receipt of new patents in the U.S., Canada, and Europe, bringing its total global patent portfolio to 70.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading